CorMedix Inc. (CRMD) Social Stream
CORMEDIX INC (CRMD) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CRMD.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 2 | $29 | $27 | $28 | $3.61 | 675.62% |
| 2022-05-12 | 1 | $27 | $27 | $27 | $3.61 | 647.92% |
| 2022-08-09 | 3 | $27 | $14 | $20.5 | $3.61 | 467.87% |
| 2022-08-12 | 3 | $16 | $12 | $14 | $3.61 | 287.81% |
| 2022-10-18 | 3 | $18 | $12 | $14.666 | $3.61 | 306.26% |
| 2022-11-11 | 3 | $18 | $13 | $15 | $3.61 | 315.51% |
| 2023-03-03 | 3 | $18 | $13 | $15.666 | $3.61 | 333.96% |
| 2023-05-15 | 3 | $18 | $13 | $15.666 | $3.61 | 333.96% |
| 2023-08-08 | 4 | $19 | $12 | $16.333 | $3.61 | 352.44% |
| 2023-08-10 | 4 | $19 | $6 | $13.75 | $3.61 | 280.89% |
| 2023-11-15 | 4 | $19 | $10 | $14.25 | $3.61 | 294.74% |
The Trend in the Analyst Price Target
CRMD's average price target has moved up $1.25 over the prior 43 months.
Over the past 37 weeks, CRMD's average upside potential has been 268.46%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-31 | 3 | 18 | 13 | 15.666 | 4.14 | 278.41% |
| 2023-08-08 | 4 | 19 | 13 | 16.666 | 4.42 | 277.06% |
| 2023-08-08 | 3 | 19 | 12 | 16.333 | 4.42 | 269.52% |
| 2023-08-08 | 3 | 19 | 13 | 16.666 | 4.42 | 277.06% |
| 2023-11-15 | 4 | 19 | 10 | 14.750 | 3.33 | 342.94% |
CRMD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 2 | 2 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 15 months, CRMD's average broker recommendation rating worsened by 0.17.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- CRMD has a greater upside potential (average analyst target price relative to current price) than 1480.83% of all US stocks.
- CRMD has a higher number of analysts covering the stock than 122.69% of all US stocks.
- In the context of Pharmaceutical Products stocks, CORMEDIX INC's variance in analysts' estimates is lower than -379.28% of them.
- CORMEDIX INC's average analyst price target is greater than 508.87% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CORMEDIX INC are MDVL, SLS, and ATNM.
View All Top Stocks by Price Target
What is the outlook for CRMD? Use POWR Ratings for clearer insight into price direction.